Here are some of the latest health and medical news
developments, compiled by the editors of
Number of Insured Americans Drops for First Time in Decades:
For the first time in 23 years, there was a decrease in the
number of Americans with health insurance, from 255.1 million in
2008 to 253.6 million in 2009, according to the U.S. Census
"This is a pretty dramatic development. It's not just a percentage drop but a drop in the actual number of people who had health insurance," Deborah Chollet, senior fellow and health economist at Mathematica Policy Research, told CNNMoney.com.
"It also points to the obvious need for health reform," she added.
This is the first decline since the federal government began
collecting health insurance data in 1987. The Census Bureau also
said that between 2008 and 2009:
"Historically what we've seen during recessions and then job recovery is that when unemployed people find new jobs, more of the newly employed find jobs that don't offer health coverage. This may be happening now.," Chollet told CNNMoney.com.
Soil Amoeba Caused Transplant Patients' Deaths: Officials
Two organ transplant recipients in Arizona died of a brain
infection from an amoeba that was passed from their organ donor,
say health officials.
The deaths were caused by
Balamuthia mandrillaris, which is found in soil and is especially dangerous to transplant patients, who are given drugs to suppress their immune system in order to reduce the risk of organ rejection, the Associated Press reported.
The two patients were a 56-year-old male liver recipient who
died Aug. 17 and a 24-year-old male kidney and pancreas recipient
who died Aug. 30. The donor was a 27-year-old male landscaper who
died from what was believed to be a stroke.
Two other patients received organs, one a heart and another a
kidney, from the same donor but are alive and have no symptoms, the
This is the second confirmed cluster of transplant-related
encephalitis caused by this microscopic parasite. The previous
cluster occurred last year in Mississippi.
Celexa Maker Pays $313 Million To Settle Charges
The company that makes the antidepressant Celexa has agreed to
pay more than $313 million to settle criminal charges and civil
complaints arising from its marketing of the drug, the U.S.
government said Wednesday.
The Justice Department took action against Forest
Pharmaceuticals, a unit of Forest Laboratories, for a number
The New York Times reported.
These included marketing Celexa to treat children and
adolescents, even though the drug was approved only for treatment
of depression in adults. Federal prosecutors also charged that
Forest publicized positive findings from a study on Celexa in
adolescents but didn't inform doctors about another study that
yielded negative findings.
The government also alleged that Forest paid physicians to
persuade them to prescribe Celexa and another antidepressant called
The Times reported.
"Forest pharmaceuticals deliberately chose to pursue corporate profits over its obligations to the FDA and the American public," Carmen Ortiz, the United States attorney for the District of Massachusetts, said in a federal government news release.
Scientists Create First Artificial Ovary
The world's first artificial ovary has been created by U.S.
scientists, who said their success could benefit infertile women
and help preserve fertility in women facing cancer treatments.
The lab-grown ovary has already been used to mature human eggs,
said the researchers at Brown University and Women & Infants
Hospital in Rhode Island,
"An ovary is composed of three main cell types, and this is the first time that anyone has created a 3-D tissue structure with triple cell line," Sandra Carson, professor of obstetrics and gynecology at the Warren Alpert Medical School of Brown University and director of the Division of Reproductive Endocrinology and Infertility at Women & Infants Hospital, said in a news release from the school.
The research appears in the
Journal of Assisted Reproduction and Genetics.
Chuck E. Cheese Toys Recalled
A recall of more than 1.2 million Chuck E. Cheese light-up rings
and toy eyeglasses was announced Wednesday, says the U.S. Consumer
Product Safety Commission.
The agency said the Chinese-made toys can break and expose the
small batteries inside, which might be swallowed by small children
and cause esophagus, stomach or intestine problems, the
Associated Press reported.
So far, there have been no reported injuries but two children
did remove batteries from light-up rings. One child swallowed a
battery and another put a battery up his nose, the CPSC said.
The toys should be taken from children and returned for a refund
of cash or prizes.
This is the fourth time since 2001 that Texas-based Chuck E.
Cheese has been involved in recalls of children's toys, the
Many Medical Residents Work While Sick: Study
Doctors typically tell sick patients not to go to work, but many
junior doctors don't follow that basic health rule, finds a new
An analysis of an anonymous survey of 537 medical residents at
12 U.S. hospitals conducted last year found that nearly 58 percent
said they had worked at least once while sick and 31 percent said
they had worked more than once while sick in the previous year, the
Associated Press reported.
About half of the respondents claimed they didn't have time to
see a doctor about their illness.
The study was published Wednesday in the
Journal of the American Medical Association.
The survey used in the study was conducted by the Accreditation
Council for Graduate Medical Education. Council CEO Dr Thomas Nasca
AP that residents are trained to put patients' needs before
their own. However, they need to understand that if they're sick,
it would be better for their patients if they were seen by other
Please be aware that this information is provided to supplement the care provided by your physician. It is neither intended nor implied to be a substitute for professional medical advice. CALL YOUR HEALTHCARE PROVIDER IMMEDIATELY IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with any questions you may have regarding a medical condition.
Copyright © EBSCO Publishing. All rights reserved.